$ Value
$6.2M
Shares
547,430
Price
$11
Filed
Jun 6
Insider
Name
Ramaswamy Vivek
Title
—
CIK
0001635075
Roles
Transaction Details
Transaction Date
2025-06-04
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
38,627,181
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.25 to $11.47, inclusive. The reporting person undertakes to provide to Roivant Sciences Ltd., any security holder of Roivant Sciences Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.16 to $11.31, inclusive. | Represents the quantity of shares held indirectly only
Filing Info
Ramaswamy Vivek's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-20 | ROIV | ▼ | $6.6M |
| 2025-06-18 | ROIV | ▼ | $6.5M |
| 2025-06-06 | ROIV | ▼ | $2.2M |
| 2025-06-04 | ROIV | ▼ | $6.2M |
| 2025-05-07 | ROIV | ▼ | $7.0M |
| 2025-05-06 | ROIV | ▼ | $3.1M |
Other Insiders at ROIV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MOMTAZEE JAMES C | — | — | 2026-04-17 |
| Fitzgerald Meghan | — | $1.9M | 2026-03-26 |
| Oren Ilan | — | — | 2026-04-17 |
|
Torti Frank
President and Vant Chair
|
— | — | 2026-03-31 |
|
Sukhatme Mayukh
President & CIO
|
— | — | 2026-03-31 |
|
Gline Matthew
CEO
|
— | $8.4M | 2026-04-16 |
|
Venker Eric
President & Immunovant CEO
|
— | $5.9M | 2026-04-20 |
| Epperly Melissa B, | — | — | 2026-04-17 |
|
Pulik Richard
CFO
|
— | — | 2026-04-20 |
|
Humes Jennifer
Chief Accounting Officer
|
— | $384K | 2026-04-20 |